🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke

Recruitingn/aAges 18 Years - 55 YearsAllThe Florey Institute of Neuroscience and Mental H…
NCT07019493 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Investigators are running a small, early-phase research study across several hospitals in Melbourne, Australia. The study will involve up to 100 young adults between the ages of 18 and 55 who have had a stroke. The goal is to test how practical it is to carry out a detailed health assessment process-called "deep phenotyping"-with this group. This process involves collecting a wide range of information and samples from stroke survivors to better understand each participant's condition. The Investigators will look at how well this approach works in practice, including how easy it is to use, whether it's done consistently, and how acceptable it is to participants. At the same time, the Investigators will also explore how different factors-such as biological markers (biomarkers), age, sex, type of stroke, lifestyle, and environment-might be related to stroke recovery. This pilot study

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Between 18 and 55 years. 2. Within one month of acute stroke confirmed with standard of care brain imaging or clinical diagnosis or for those for whom recruitment \<1 month of stroke is not possible they may be recruited to participate within 3-months of stroke Exclusion Criteria: 1. Severe, intercurrent or progressive illness likely to EITHER 1. Have a prognosis for survival under 24 months; OR 2. In the opinion of the investigator will mask the importance to the individual participant data (e.g. severe MS, dementia, etc) 2. Major psychiatric condition requiring medical intervention
💊

What it tests

  • Observational Cohort
📍

Where

2 sites
Austin Health
Heidelberg, Australia
Florey Institute of Neuroscience and Mental Health, Melbourne Brain Centre
Heidelberg, Australia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy